摘要
目的 观察沐舒坦治疗重症高血压脑出血并肺部感染的临床疗效及安全性。方法 选择GCS评分 4～ 8分重症高血压脑出血并肺部感染患者 86例 ,随机选 43例 (实验组 )加用沐舒坦静脉推注治疗 ,另 43例 (对照组 )未予沐舒坦治疗。所有患者其他治疗措施基本相同。结果 实验组有 3 8例感染得到控制 ,占 88.4% ,感染控制时间为 ( 8.4± 2 .1)d ;对照组有 3 0例感染得到控制 ,占 69.8% ,感染控制时间为 ( 14 .3± 3 .0 )d。实验组肺部感染控制率显著高于对照组 (P <0 .0 5) ,而控制感染平均时间显著短于对照组 (P <0 .0 5)。两组均无明显的不良反应发生。结论 沐舒坦治疗重症高血压脑出血并肺部感染安全有效 。
Objective It is to study the clinical effect and s afety of mucosolvan on severe hypertensive intracerebral hemorrhage (SHIH) combined with lung infect ion. Methods 86 patients with SHIH combined with lung infection (Glas gow Coma Scale S core of 4～8) were randomized into experiment group and control group. The exper i ment group were treated with mucosolvan and the control group were treated witho ut mucosolvan. The other treatment methods for all patients were similar. Results Lung infection of 38 patients (88.4%) in the experiment group and 30 pat ients (69.8%) in the control group were controlled. The time of lung infection c ontrolled in the experiment group and the control group were (8.4±2.1)d and (14 .3±3.0)d respectively. The rate of lung infection controlled in the experiment group was significantly higher than that in the control group ( P <0.05) and t he t ime of lung infection controlled in the experiment group was shorter than that i n the control group ( P <0.05). Conclusion The effect of mucosolvan on SHIH combined with lung i nfection is effective and safety. It deserves further clinical applications.
出处
《现代中西医结合杂志》
CAS
2003年第18期1934-1935,共2页
Modern Journal of Integrated Traditional Chinese and Western Medicine
